8 results
8-K
EX-99.1
IMNM
Immunome, Inc.
13 Feb 24
Results of Operations and Financial Condition
4:10pm
Drug Rebate Program and the 340B Drug Pricing Program. The Medicaid Drug Rebate Program requires biopharmaceutical manufacturers to enter into and have … outpatient therapeutic products furnished to Medicaid patients. Under the 340B Drug Pricing Program, the manufacturer must extend discounts to entities
10-K
2020 FY
IMNM
Immunome, Inc.
25 Mar 21
Annual report
5:01pm
in other government healthcare programs, including the Medicaid Drug Rebate Program and the 340B Drug Pricing Program. The Medicaid Drug Rebate Program … the 340B Drug Pricing Program, the manufacturer must extend discounts to entities that participate in the program.
Different pricing and reimbursement
424B4
IMNM
Immunome, Inc.
5 Oct 20
Prospectus supplement with pricing info
5:10pm
Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, review … and biosimilar drugs. On March 10, 2020, the Trump administration sent “principles” for drug pricing to Congress, calling for legislation that would
S-1/A
jspgpierkmb8x3u00
24 Sep 20
IPO registration (amended)
7:18am
S-1
dyhbcsl
9 Sep 20
IPO registration
4:19pm
DRS
gp8jpvd4nliw2wdd
12 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next